日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful engraftment in myeloablative transplant with cadaveric bone marrow after sudden unavailability of living donor

在活体供者突然无法获得的情况下,使用尸体骨髓进行清髓性移植,并成功植入。

Vasu, Sumithira; Wall, Sarah; Larkin, Karilyn; Munjal, Sagar; de Lima, Marcos; Sanchez-Petitto, Gabriela

Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm

塔格拉索福普对初治浆细胞样树突状细胞肿瘤患者的造血作用

Konopleva, Marina; Pemmaraju, Naveen; Sweet, Kendra L; Stein, Anthony S; Rizzieri, David A; Wang, Eunice S; Vasu, Sumithira; Rosenblat, Todd; Zuurman, Michael; Gupta, Ira; Lane, Andrew A

Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial

供体搜索和选择策略旨在促进不同供体搜索预后组之间移植率的可比性:来自 BMT CTN 1702 试验的报告

Pidala, Joseph; Logan, Brent; Lee, Stephanie J; Shaw, Bronwen E; Devine, Steven; Ciurea, Stefan O; Horowitz, Mary; He, Naya; Pusic, Iskra; Srour, Samer A; Arai, Sally; Juckett, Mark; Uberti, Joseph; Hill, LaQuisa; Vasu, Sumithira; Hogan, William J; Hayes-Lattin, Brandon; Westervelt, Peter; Bashey, Asad; Farhadfar, Nosha; Grunwald, Michael R; Leifer, Eric; Symons, Heather; Saad, Ayman; Vogel, Jenny; Erickson, Connor; Buck, Kelly; Dehn, Jason G

Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial

基于供体搜索预后的异基因细胞移植机会:BMT CTN 1702 试验

Dehn, Jason G; Logan, Brent; Lee, Stephanie J; Shaw, Bronwen E; Devine, Steven; Ciurea, Stefan O; Horowitz, Mary; He, Naya; Pusic, Iskra; Srour, Samer A; Arai, Sally; Juckett, Mark; Uberti, Joseph; Hill, LaQuisa; Vasu, Sumithira; Hogan, William J; Hayes-Lattin, Brandon; Westervelt, Peter; Bashey, Asad; Farhadfar, Nosha; Grunwald, Michael R; Leifer, Eric; Symons, Heather; Saad, Ayman; Vogel, Jenny; Erickson, Connor; Buck, Kelly; Pidala, Joseph

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemia

一项评估鲁索替尼联合维奈托克治疗复发/难治性急性髓系白血病患者的1期临床试验结果

Borate, Uma; Tognon, Cristina E; Madanat, Yazan F; Misra, Shikha; Kaempf, Andy; Patel, Prapti A; Davis, Kara L; Sun, Junwei; Stuani, Lucille; Eisenmann, Eric D; Eide, Christopher A; Kurtz, Stephen E; Watanabe-Smith, Kevin; Johnson, Kara; Jager, Astraea; Gullaksen, Stein-Erik; Robinson, Bridget; Vu, Tania; Plevritis, Sylvia K; Baker, Sharyn D; Minnier, Jessica; Clement, Peter; Avaylon, Sammantha; Hayes, Madison; Newell, Laura F; Gandhi, Arpita P; Leonard, Jessica; Hayes-Lattin, Brandon; Vasu, Sumithira; Cook, Rachel J; Meyers, Gabrielle; Maziarz, Richard T; Traer, Elie; Swords, Ronan; Tyner, Jeffrey W; Druker, Brian J; Saultz, Jennifer N

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation

来自血液和骨髓移植临床试验网络1702的主要结果:替代供体异基因移植的临床移植相关长期结果

Lee, Stephanie J; Logan, Brent; Horowitz, Mary M; Dehn, Jason G; Pidala, Joseph; Grunwald, Michael R; Westervelt, Peter; Farhadfar, Nosha; Hogan, William J; Bashey, Asad; Hayes-Lattin, Brandon; Hill, LaQuisa; Brunstein, Claudio; Arai, Sally; Srour, Samer A; Symons, Heather; Uberti, Joseph; Vasu, Sumithira; Pusic, Iskra; Juckett, Mark; Leifer, Eric; He, Naya; Devine, Steven; Shaw, Bronwen E; Ciurea, Stefan O

Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies

血液系统恶性肿瘤患者接受 CAR-T 细胞治疗后发生的第二原发性恶性肿瘤

Umyarova, Elvira; Pei, Charles; Pellegrino, William; Zhao, Qiuhong; Sharma, Nidhi; Benson, Don; Cottini, Francesca; Bezerra, Evandro; Brammer, Jonathan; Bumma, Naresh; Choe, Hannah; Denlinger, Nathan; Devarakonda, Srinivas; Khan, Abdullah; Penza, Sam; Rosko, Ashley; Vasu, Sumithira; Wall, Sarah; Alinari, Lapo; Baiocchi, Robert; Bond, David A; Christian, Beth; Hanel, Walter; Maddocks, Kami; Reneau, John; Sawalha, Yazeed; Habib, Alma; Sigmund, Audrey; Voorhees, Timothy J; de Lima, Marcos; Epperla, Narendranath

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

对于FLT3-ITD突变型急性髓系白血病患者,可测量的残留病灶和移植后吉瑞替尼维持治疗。

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Nagler, Arnon; Wei, Andrew H; Marcucci, Guido; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变和可测量残留病灶对FLT3-ITD急性髓系白血病的影响

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason E; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation

异基因造血干细胞移植后克隆性造血和心脏事件的发生

Quartermaine, Cooper; Braunstein, Zach; Shaaban, Adnan; Habib, Alma; Kola-Kehinde, Onaopepo; McLaughlin, Eric; Sughra, Sana; Ghazi, Sanam; Ruiz, Miguel; Toomey, Amelia; Ferdousi, Mussammat; Ruz, Patrick; Sharma, Sneha; Sansoterra, Stephen; Byun, Woo Yul; Vasu, Sumithira; Jaglowski, Samantha; Penza, Sam; de Lima, Marcos J; Choe, Hannah; Boateng, Isaiah; Byrd, John C; Brammer, Jonathan E; Addison, Daniel